Skip to main content
. 2000 Mar;99(3):440–450. doi: 10.1046/j.1365-2567.2000.00960.x

Table 2.

The different primers used in this work

CD18 mRNA amplification
Coding Non-coding Size (bp)
 CD18-1: TATAAGCTTCAGGGCAGACTGGTAGCAAA CD18–4: CTTAGCAAGCTTGTGCGCCA 1–1007
 CD18-5: AACGAATTCGACTACCCATCGGT CD18–8: CTAGAATTCTCCTGACGGCCTTGTCTTCA 970–2410
HVS genome amplification
Coding Non-coding Size (bp)
 HVS.1: GAGTTTCCAAAATGTACTAAGCTAAC HVS.2-ACTAATAAAAAGTTCCACACAACTAAC 89
CD18 genomic DNA amplification
Coding Non-coding Localization (size bp)
 CD18-1.1: GACATCATGGACCCCACAAGC CD18–1·2: CTTCAGCACGTGCCTGAAGGC Exon 4–exon 6 (5400)
 I4F-1: CTGAAACTCCAGCCTGCCTGG I5R-2: TACAAGTGTTGGGGAGCCAGG Intron 4–intron 5 (572)
Direct sequencing
Primer Localization
 CD18-2: AACAAGCTTCTTGACATTCC Exon 5
 CD18-3: TCCAAGCTTGATGACCTCAG Exon 5
 I5R-2: TACAAGTGTTGGGGAGCCAGG Intron 5
 I5R-1: AGATGGAAGGGGAAGTGGAGG Intron 5
Competitive PCR analysis
Coding Non-coding Localization (size bp)
 E4-FM: TAMRA-CTTCACAGGGCCGGGGGATCC E4-R: CTGGTCGCAGGTAAAGCGTCT Exon 4 (180)
 E5-RM: TAMRA-GTCCTGCAGTGCCTGGGCC I4F-3: GGGGAGAGGGGAGGTCAGGAG Exon 5–intron 4 (*)
 E6-FM: TAMRA-CTTCGGGTCCTTCGTGGACAAG E6-R: GGGCAGGCGGCGACCTGCATCA Exon 6 (240)
*

Amplified size in CT-HVS was 331 bp and in LAD-HVS was 162 bp.